Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia
· Delayed Price · Currency is AUD 3.290
-0.290 (-8.10%)
Mar 9, 2026, 3:39 PM AEST
Clarity Pharmaceuticals Revenue
Clarity Pharmaceuticals had revenue of 5.81M AUD in the half year ending December 31, 2025, with 7.15% growth. This brings the company's revenue in the last twelve months to 10.58M, down -1.83% year-over-year. In the fiscal year ending June 30, 2025, Clarity Pharmaceuticals had annual revenue of 9.46M, down -17.76%.
Revenue (ttm)
10.58M
Revenue Growth
-1.83%
P/S Ratio
125.89
Revenue / Employee
120.23K
Employees
88
Market Cap
1.33B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PYC Therapeutics | 20.56M |
| Neuren Pharmaceuticals | 64.65M |
| Opthea | -20.12K |
| Mesoblast | 98.02M |
| Immutep | 7.92M |
| Clinuvel Pharmaceuticals | 96.30M |
| Telix Pharmaceuticals | 1.21B |
| Racura Oncology | 3.48M |